606
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

The placenta in fetal thyroid hormone delivery: from normal physiology to adaptive mechanisms in complicated pregnancies

ORCID Icon, , , , , & show all
Pages 3857-3866 | Received 09 Dec 2018, Accepted 21 Feb 2019, Published online: 19 Mar 2019

References

  • Laudet V. The origins and evolution of vertebrate metamorphosis. Curr Biol. 2011;21(18):R726–R737.
  • Moog NK, Entringer S, Heim C, et al. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017;342:68–100.
  • Fisher DA. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev PER. 2007;4(4):317–328.
  • Contempré B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab. 1993;77(6):1719–1722.
  • Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab. 2002;87(4):1768–1777.
  • Jauniaux E, Jurkovic D, Campbell S. In vivo investigations of the anatomy and the physiology of early human placental circulations. Ultrasound Obstet Gynecol. 1991;1(6):435–445.
  • McKinnon B, Li H, Richard K, et al. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinol Metab. 2005;90(12):6714–6720.
  • Patel J, Landers KA, Li H, et al. Ontogenic changes in placental transthyretin. Placenta. 2011;32(11):817–822.
  • Zhu L, Baczyk D, Lye SJ, et al. Preeclampsia is associated with low placental transthyretin levels. Taiwan J Obstet Gynecol. 2016;55(3):385–389.
  • Patel J, Landers KA, Mortimer RH, et al. Expression and uptake of the thyroxine-binding protein transthyretin is regulated by oxygen in primary trophoblast placental cells. J Endocrinol. 2012;212(2):159–167.
  • Mortimer RH, Landers KA, Balakrishnan B, et al. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta. Placenta. 2012;33(4):252–256.
  • Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab. 2009;5(1):45–54.
  • Loubière LS, Vasilopoulou E, Bulmer JN, et al. Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta. 2010;31(4):295–304.
  • Schwartz CE, May MM, Carpenter NJ, et al. Allan–Herndon–Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet. 2005;77(1):41–53.
  • Friesema EC, Jansen J, Jachtenberg JW, et al. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol. 2008;22(6):1357–1369.
  • Larsen PR, Zavacki AM. The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action. Eur Thyroid J. 2012;1(4):232–242.
  • Chan S, Kachilele S, Hobbs E, et al. Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab. 2003;88(9):4488–4495.
  • Stulp MR, de Vijlder JJ, Ris-Stalpers C. Placental iodothyronine deiodinase III and II ratios, mRNA expression compared to enzyme activity. Mol Cell Endocrinol. 1998;142(1–2):67–73.
  • Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, et al. Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab. 1996;81(6):2154–2158.
  • Hernandez A, Martinez ME, Fiering S, et al. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest. 2006;116(2):476–484.
  • Mortimer RH, Galligan JP, Cannell GR, et al. Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab. 1996;81(6):2247–2249.
  • Kilby MD, Verhaeg J, Gittoes N, et al. Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab. 1998;83(8):2964–2971.
  • Banovac K, Ryan EA, O’Sullivan MJ. Triiodothyronine (T3) nuclear binding sites in human placenta and decidua. Placenta. 1986;7(6):543–549.
  • Visser TJ. Role of sulfation in thyroid hormone metabolism. Chem Biol Interact. 1994;92(1–3):293–303.
  • Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404–433.
  • Moreno-Reyes R, Glinoer D, Van Oyen H, et al. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab. 2013;98(9):3694–3701.
  • Henrichs J, Ghassabian A, Peeters RP, et al. Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why? Clin Endocrinol (Oxf). 2013;79(2):152–162.
  • Dosiou C, Barnes J, Schwartz A, et al. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab. 2012;97(5):1536–1546.
  • Chan S, Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol (Oxf). 2015;82(3):313–326.
  • Nazarpour S, Tehrani FR, Simbar M, et al. Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. Eur J Endocrinol. 2016;174(1):77–83.
  • Ngene NC, Moodley J. Role of angiogenic factors in the pathogenesis and management of pre-eclampsia. Int J Gynaecol Obstet. 2018;141(1):5–13.
  • Baergen RN. Manual of Benirschke and Kaufmann’s pathology of the human placenta. New York: Springer; 2005. Chapter 18, Placental malperfusion.
  • Fogarty NM, Ferguson-Smith AC, Burton GJ. Syncytial knots (Tenney-Parker changes) in the human placenta: evidence of loss of transcriptional activity and oxidative damage. Am J Pathol. 2013;183(1):144–152.
  • Sun YN, Liu YJ, Zhang L, et al. Expression of organic anion transporting polypeptide 1c1 and monocarboxylate transporter 8 in the rat placental barrier and the compensatory response to thyroid dysfunction. PLoS One. 2014;9(4):e96047.
  • Chan SY, Franklyn JA, Pemberton HN, et al. Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol. 2006;189(3):465–471.
  • Vasilopoulou E, Loubière LS, Martín-Santos A, et al. Differential triiodothyronine responsiveness and transport by human cytotrophoblasts from normal and growth-restricted pregnancies. J Clin Endocrinol Metab. 2010;95(10):4762–4770.
  • Kurlak LO, Mistry HD, Kaptein E, et al. Thyroid hormones and their placental deiodination in normal and pre-eclamptic pregnancy. Placenta. 2013;34(5):395–400.
  • Eerdekens A, Langouche L, Güiza F, et al. Maternal and placental responses before preterm birth: adaptations to increase fetal thyroid hormone availability? J Matern Fetal Neonatal Med. 2018:1–12.
  • Hidal JT, Kaplan MM. Characteristics of thyroxine 5’-deiodination in cultured human placental cells. Regulation by iodothyronines. J Clin Invest. 1985;76(3):947–955.
  • Burmeister LA, Pachucki J, St. Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre and posttranslational mechanisms. Endocrinology. 1997;138(12):5231–5237.
  • Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321(1):13–16.
  • Fruscalzo A, Schmitz R, Klockenbusch W, et al. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome. Histochem Cell Biol. 2012;138(6):925–932.
  • Simeoni U, Armengaud JB, Siddeek B, et al. Perinatal origins of adult disease. Neonatology. 2018;113(4):393–399.
  • Forhead AJ, Curtis K, Kaptein E, et al. Developmental control of iodothyronine deiodinases by cortisol in the ovine fetus and placenta near term. Endocrinology. 2006;147(12):5988–5994.
  • Forhead AJ, Jellyman JK, Gardner DS, et al. Differential effects of maternal dexamethasone treatment on circulating thyroid hormone concentrations and tissue deiodinase activity in the pregnant ewe and fetus. Endocrinology. 2007;148(2):800–805.
  • Manojlović-Stojanoski MN, Filipović BR, Nestorović NM, et al. Morpho-functional characteristics of rat fetal thyroid gland are affected by prenatal dexamethasone exposure. Steroids. 2014;84:22–29.
  • Slone-Wilcoxon J, Redei EE. Maternal-fetal glucocorticoid milieu programs hypothalamic-pituitary-thyroid function of adult offspring. Endocrinology. 2004;145(9):4068–4072.
  • Filis P, Hombach-Klonisch S, Ayotte P, et al. Maternal smoking and high BMI disrupt thyroid gland development. BMC Med. 2018;16(1):194.
  • Posod A, Odri Komazec I, Pupp Peglow U, et al. Former very preterm infants show alterations in thyroid function at a preschool age. BioMed Res Int. 2017;2017:1–5.
  • Forhead AJ, Fowden AL. Thyroid hormones in fetal growth and prepartum maturation. J Endocrinol. 2014;221(3):R87–R103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.